Ravikrishnan, J., Diaz-Rohena, D. Y., Muhowski, E., Mo, X., Lai, T.-H., Misra, S., Williams, C. D., Sanchez, J., Mitchell, A., Satpati, S., Perry, E., Kaufman, T., Liu, C., Lozanski, A., Lozanski, G., Rogers, K., Kittai, A. S., Bhat, S. A., Collins, M. C., Davids, M. S., Jain, N., Wierda, W. G., Lapalombella, R., Byrd, J. C., Tan, F., Chen, Y., Chen, Y., Shen, Y., Anthony, S. P., Woyach, J. A. and Sampath, D. (2020) “LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.284353.